Physician profile
Bryan C Husta
NPI 1871760983
$283,447.20
in general payments reported to CMS, 2019-2025
11 companies · $8,288 in 2025
The $8,288 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,017 · 2020: $16K · 2021: $56K · 2022: $80K · 2023: $73K · 2024: $42K · 2025: $8,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $86K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $12K · Food and Beverage: $3,707 · Consulting Fee: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $86,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,600.00 |
| Travel and Lodging | $12,359.20 |
| Food and Beverage | $3,706.57 |
| Consulting Fee | $2,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $274,589.71 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Siemens Medical Solutions USA, INC. | $3,603.59 | 2021-2022 | |
| Serpex Medical INC | $2,422.43 | 2024-2025 | |
| Medtronic USA, INC. | $1,341.76 | 2019 | |
| Boston Scientific Corporation | $417.99 | 2019-2024 | |
| Veran Medical Technologies, INC. | $407.07 | 2019 | |
| Ethicon INC. | $260.36 | 2021-2023 | Monarch Platform |
| Galvanize Therapeutics, INC | $164.96 | 2023 | Aliya System |
| Steris Corporation | $157.66 | 2023 | |
| Pulmonx Corporation | $81.67 | 2025 | Zephyr Delivery Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Husta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.